entertainment -WSS

entertainment

author：leisure time 2025-09-06 05:03:07 - browse：218

As elite hunters of the immune system, T cells are constantly prowling our bodies for diseased cells to attack. But when they encounter a tumor, something unexpected can happen. New research shows that some cancer cells can fire a long nanotube projection into the T cell that, like a vampire’s fang, sucks energy-creating mitochondria from the immune cell, turning the predator into prey.

A study published this week in Cancer Cell investigated how cancer cells can rob mitochondria from T cells, shutting the immune cell down while energizing themselves. It may be yet another way cancer overcomes both the body’s defenses and resists many immunotherapies like CAR-T therapy and immune checkpoint blockade drugs, experts said.

“This is a new mechanism of immune evasion. It seems like the cancer cells are draining mitochondria from the T cells,” said Bo Li, a cancer researcher at the University of Pennsylvania and a senior author on the paper. “It’s really amazing. Some of my colleagues, their reaction was like, ‘I can’t believe this is true.’ I understand that. It’s just like the cancer cell is too smart.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： When is a doctor not a doctor? Try when patients address women doctors

explore

WSS

Microbiome research is starting to find links to chronic diseases

It's been 20 years since Dolly the sheep. Where's my clone?

Microbiome research is starting to find links to chronic diseases

PhRMA sues HHS over Medicare drug price negotiation

4th of July breaks record for highest global temperature ever measured

Option Care buys Amedisys in $3.6 billion home care deal

knowledge

entertainment

Wikipedia

In age of alternative facts, a scholarly course on calling out crap

Duchenne patients, backed by ‘dark money’ group, to debate drug prices

The high cost of giving birth even with insurance

4th of July breaks record for highest global temperature ever measured

BioMarin wins approval for gene therapy to treat hemophilia A

Readout LOUD podcast: possible new ALS drug, artificial wombs

What does generative AI mean for health care? We asked experts

Inside the fall of star MIT scientist David Sabatini

Hollywood unions extend contract negotiations for actors

Microbiome research is starting to find links to chronic diseases

hotspot

It's been 20 years since Dolly the sheep. Where's my clone?

Option Care buys Amedisys in $3.6 billion home care deal

Bacterial infection may be ‘key event’ in endometriosis, study says

Listen: Biogen's messy board & Laronde's data problem

Hearing on Medicare drug price negotiation gets unusually heated

CDC's new outbreak response network to include Northeastern

focus

explore

knowledge

hotspot